Delayed and extended release mesalazine

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	3

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00548574 (ClinicalTrials.gov)	December 4, 2003	23/10/2007	Efficacy andSafety of Two Doses of SPD476 (Mesalazine) 2.4g and4.8g Once Daily, With Reference to As ...	A Phase III, Randomized, Multi-Centre, Double-blind, Double Dummy, Parallel Group, Placebo-Controlle ...	Ulcerative Colitis	Drug: SPD476 is a polymeric matrix formulation that displays both delayed- and extended-releaseof me ...	Shire	NULL	Completed	18 Years	N/A	All	343	Phase 3	Belgium
2	NCT00503243 (ClinicalTrials.gov)	September 30, 2003	16/7/2007	Safety andEfficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single ...	A Phase III, Randomized, Multi-Centre, Double-Blind, Parallel Group, Placebo-Controlled Study to Eva ...	Colitis, Ulcerative	Drug: Delayed and extended release mesalazine	Shire	NULL	Completed	18 Years	N/A	All	280	Phase 3	United States
3	NCT00545389 (ClinicalTrials.gov)	February 10, 2003	16/10/2007	Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476 ...	A Phase II, Randomized, Multi-centre, Double-blind, Parallel-group, Dose-ranging, Exploratory Study ...	Colitis, Ulcerative	Drug: SPD476 is a polymeric matrix formulation that displays both delayed- and extended-releaseof me ...	Shire	NULL	Completed	18 Years	N/A	All	38	Phase 2	Belgium

First Previous1Next Last